Back to
NORTHERN TRUST CORP
FDMT22 quarters
Position history for
NORTHERN TRUST CORP's holdings in 4D MOLECULAR THERAPEUTICS IN
NORTHERN TRUST CORP holds 562,929 shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $7.5M as of 2026-Q2. The position was increased (+64.6% shares). FDMT represents 0.0% of NORTHERN TRUST CORP's portfolio.
Current Value
$7.5M
Current Shares
562,929
Total Value Change
+$3.7M
Total Shares Change
+475,786
Quarter-by-Quarter History
Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc.